Catarina F. Pulido

Lisbon, Portugal

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Unveiling the traits of HER2-low breast cancer: a comparative analysis of IHC1+ vs IHC2+/ISH-negative subgroups - insights from a 3-year cohort study.

Unveiling the traits of HER2-low breast cancer: a comparative analysis of IHC1+ vs IHC2+/ISH-negative subgroups - insights from a 3-year cohort study.

Journal: Frontiers in oncology

Published: July 28, 2025

Long-Term Safety and Efficacy of the Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Injection in Patients With HER2-Positive Early Breast Cancer in PHranceSCa, a Randomized, Open-Label Phase II Study.

Long-Term Safety and Efficacy of the Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Injection in Patients With HER2-Positive Early Breast Cancer in PHranceSCa, a Randomized, Open-Label Phase II Study.

Journal: Clinical breast cancer

Published: April 01, 2025

Case report: Treatment with Phesgo® in a patient receiving hemodialysis.

Case report: Treatment with Phesgo® in a patient receiving hemodialysis.

Journal: Frontiers in oncology

Published: December 02, 2023

Loss of RAS Mutations in Liquid Biopsies of Patients With Multi-Treated Metastatic Colorectal Cancer.

Loss of RAS Mutations in Liquid Biopsies of Patients With Multi-Treated Metastatic Colorectal Cancer.

Journal: The oncologist

Published: July 17, 2023

SARS-CoV-2 Antibody Seroprevalence in Patients With Cancer on Systemic Antineoplastic Treatment in the First Wave of the COVID-19 Pandemic in Portugal.

SARS-CoV-2 Antibody Seroprevalence in Patients With Cancer on Systemic Antineoplastic Treatment in the First Wave of the COVID-19 Pandemic in Portugal.

Journal: Cureus

Published: February 21, 2022

Treatment optimization of locally advanced and metastatic pancreatic cancer (Review).

Treatment optimization of locally advanced and metastatic pancreatic cancer (Review).

Journal: International journal of oncology

Published: June 11, 2021

Levels of Circulating Fibroblast Growth Factor 23 (FGF23) and Prognosis in Cancer Patients with Bone Metastases.

Levels of Circulating Fibroblast Growth Factor 23 (FGF23) and Prognosis in Cancer Patients with Bone Metastases.

Journal: International journal of molecular sciences

Published: January 17, 2019

Chemoradiotherapy completion and neutropenia risk in HIV patients with cervical cancer.

Chemoradiotherapy completion and neutropenia risk in HIV patients with cervical cancer.

Journal: Medicine

Published: July 26, 2018

Serum YB-1 (Y-box binding protein 1) as a biomarker of bone disease progression in patients with breast cancer and bone metastases.

Serum YB-1 (Y-box binding protein 1) as a biomarker of bone disease progression in patients with breast cancer and bone metastases.

Journal: Journal of bone oncology

Published: November 30, 2016

Bone metastasis risk factors in breast cancer.

Bone metastasis risk factors in breast cancer.

Journal: Ecancermedicalscience

Published: September 19, 2016

The prognostic role of RANK SNP rs34945627 in breast cancer patients with bone metastases.

The prognostic role of RANK SNP rs34945627 in breast cancer patients with bone metastases.

Journal: Oncotarget

Published: March 02, 2016

Prevention of Nausea and Vomiting in Patients Undergoing Oral Anticancer Therapies for Solid Tumors.

Prevention of Nausea and Vomiting in Patients Undergoing Oral Anticancer Therapies for Solid Tumors.

Journal: BioMed research international

Published: November 21, 2014

Showing 1-12 of 12

Last Updated: 09/26/2026